yep :) Unfortunately, the dearth of tools means everyone (coming from as many directions) feels like they must rebuild every tool - so there is a bit of a conv

yep :) Unfortunately, the dearth of tools means everyone (coming from as many directions) feels like they must rebuild every tool - so there is a bit of a convergence right now - which spreads every tool thin. But the market for 'RNA-seq tools' is but a fraction of 'biochemical scientists', which itself is still a 'tiny' market to produce high-tech software for.